C-Protein in Fatigue and Aging

Description

This study is investigating changes to the proteins in skeletal muscle that contribute to reduced muscle size and muscle function that occurs with aging.

Conditions

Aging, Muscle Atrophy or Weakness, Sarcopenia in Elderly, Sarcopenia

Study Overview

Study Details

Study overview

This study is investigating changes to the proteins in skeletal muscle that contribute to reduced muscle size and muscle function that occurs with aging.

Skeletal Muscle Myosin Binding Protein C in Fatigue and Aging

C-Protein in Fatigue and Aging

Condition
Aging
Intervention / Treatment

-

Contacts and Locations

Eugene

University of Oregon, Eugene, Oregon, United States, 97403

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adults between the ages 18-35 or 65-80 years
  • * Healthy by self-report
  • * Willing to participate in all aspects of the study design including muscle biopsy, unilateral exercise, and physical activity monitoring
  • * Fluent in English (due to lack of translation services, it is not practical to conduct the study using a language other than English).
  • * Orthopaedic limitation (severe knee osteoarthritis, prior joint replacement, etc.).
  • * Volunteer has dementia or related mental issues that potentially put the subject at risk as determined by prior diagnosis.
  • * Volunteer has known untreated endocrine disease (hypo/hyper thyroidism, Addison's Disease or Cushing's syndrome, etc.)
  • * Volunteer has untreated/poorly-controlled hypertension (stage 2, per American College of Cardiology \[\>140/90 mmHg\]).
  • * Volunteer has significant heart, liver, kidney or respiratory disease.
  • * Volunteer has diabetes (insulin dependent or non-insulin dependent).
  • * Volunteer has known coagulopathies.
  • * Volunteer has taken anabolic steroids in the prior six months.
  • * Volunteer has received treatment for cancer (other than effective Mohs Surgery for successful removal of basal cell or squamous cell carcinomas)
  • * Unexpected weight loss \>5kg is last 12 months
  • * Volunteer is an active smoker or quit within the last year.
  • * Volunteer has known current alcohol or drug use disorder (AUD; defined as binge drinking of \>4 days in the last month. Binge drinking is \>5 drinks for men and \>4 drinks for women, per occasion). Or, if a volunteer reports drinking in excess of "low risk" per NIAAA (\>7 drinks/week for men and \>3 drinks/day for women and \>14 drinks/week and \>4 drinks/day).
  • * Volunteer has a diagnosed neuromuscular disorder.
  • * Volunteer has allergy to lidocaine.

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Oregon,

Damien M Callahan, Ph.D., PRINCIPAL_INVESTIGATOR, University of Oregon

Study Record Dates

2025-01